The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3
Abstract
Toll-like receptors (TLRs) are a family of innate immune-recognition receptors that recognize molecular patterns associated with microbial pathogens, and induce antimicrobial immune responses. Double-stranded RNA (dsRNA) is a molecular pattern associated with viral infection, because it is produced by most viruses at some point during their replication. Here we show that mammalian TLR3 recognizes dsRNA, and that activation of the receptor induces the activation of NF-kappaB and the production of type I interferons (IFNs). TLR3-deficient (TLR3-/-) mice showed reduced responses to polyinosine-polycytidylic acid (poly(I:C)), resistance to the lethal effect of poly(I:C) when sensitized with d-galactosamine (d-GalN), and reduced production of inflammatory cytokines. MyD88 is an adaptor protein that is shared by all the known TLRs. When activated by poly(I:C), TLR3 induces cytokine production through a signalling pathway dependent on MyD88. Moreover, poly(I:C) can induce activation of NF-kappaB and mitogen-activated protein (MAP) kinases independently of MyD88, and cause dendritic cells to mature.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, several RNA structural features have been described as immunostimulatory due to interactions with various RNA sensors such as Toll-like receptors, RIG-I, and PKR.”
From Sequence-engineered mRNA without chemical nucleoside modifications enables an effective protein therapy in large animals (2015) · cites this paper as [7]
In the citing paper
“Activation of TLR3 signaling by its agonists can induce apoptosis in human cancer cells [29, 33].”
From Ligand dependent restoration of human TLR3 signaling and death in p53 mutant cells (2016) · cites this paper as [33]
In the citing paper
“Through recognition of TLR3 in endosomes or retinoic acid-inducible gene I, melanoma differentiation-associated protein 5, and inflammasomes in the cytoplasm,96, 97, 98, 99 depending on the amount, dsRNAs might overactivate innate immunity and lead to adverse events.”
From COVID-19 mRNA vaccines: Platforms and current developments (2022) · cites this paper as [96]
In the citing paper
“90.7% efficacy in participants 5 to 11 years of age96”
From COVID-19 mRNA vaccines: Platforms and current developments (2022) · cites this paper as [96]
Citations
Cites
Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene
Poltorak, A., He, X., Smirnova, I., Liu, M.-Y., Huffel, C. V., Du, X., Birdwell, D., Alejos, E., Silva, M., Galanos, C., et al. (1998) · Science · doi:10.1126/science.282.5396.2085 · Cited by 7,631
A Toll-like receptor recognizes bacterial DNA
Hemmi, H., Takeuchi, O., Kawai, T., Kaisho, T., Sato, S., Sanjo, H., Matsumoto, M., Hoshino, K., Wagner, H., Takeda, K., et al. (2000) · Nature · doi:10.1038/35047123 · Cited by 6,491
A human homologue of the Drosophila Toll protein signals activation of adaptive immunity
Medzhitov, R., Preston-Hurlburt, P., & Janeway, C. A. J. (1997) · Nature · doi:10.1038/41131 · Cited by 6,137
HOW CELLS RESPOND TO INTERFERONS
Stark, G. R., Kerr, I. M., Williams, B. R. G., Silverman, R. H., & Schreiber, R. D. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.227 · Cited by 3,932
Inaba, K., Inaba, M., Romani, N., Aya, H., Deguchi, M., Ikehara, S., Muramatsu, S., & Steinman, R. M. (1992) · The Journal of Experimental Medicine · doi:10.1084/jem.176.6.1693 · Cited by 3,741
Takeuchi, O., Hoshino, K., Kawai, T., Sanjo, H., Takada, H., Ogawa, T., Takeda, K., & Akira, S. (1999) · Immunity · doi:10.1016/s1074-7613(00)80119-3 · Cited by 3,680
The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5
Hayashi, F., Smith, K. D., Ozinsky, A., Hawn, T. R., Yi, E. C., Goodlett, D. R., Eng, J. K., Akira, S., Underhill, D. M., & Aderem, A. A. (2001) · Nature · doi:10.1038/35074106 · Cited by 3,605
Hoshino, K., Takeuchi, O., Kawai, T., Sanjo, H., Ogawa, T., Takeda, Y., Takeda, K., & Akira, S. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.7.3749 · Cited by 3,374
Unresponsiveness of MyD88-deficient mice to endotoxin.
Kawai, T., Adachi, O., Ogawa, T., Takeda, K., & Akira, S. (1999) · Immunity · doi:10.1016/s1074-7613(00)80086-2 · Cited by 2,367
MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways.
Medzhitov, R., Preston-Hurlburt, P., Kopp, E., Stadlen, A., Chen, C.-Q., Ghosh, S., & Janeway, C. (1998) · Molecules and Cells · doi:10.1016/s1097-2765(00)80136-7 · Cited by 1,783
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–300 of 1,052
Endogenous toll‐like receptor ligands and their biological significance
Yu, L., Wang, L., & Chen, S. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01127.x · Cited by 555
Lee, J. Y., Ye, J., Gao, Z., Youn, H. S., Lee, W. H., Zhao, L., Sizemore, N., & Hwang, D. H. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305213200 · Cited by 524
Toll-like receptors in bony fish: From genomics to function
Palti, Y. (2011) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2011.03.006 · Cited by 526
Heil, F., Ahmad‐Nejad, P., Hemmi, H., Hochrein, H., Ampenberger, F., Gellert, T., Dietrich, H., Lipford, G. B., Takeda, K., Akira, S., et al. (2003) · European Journal of Immunology · doi:10.1002/eji.200324238 · Cited by 537
Poeck, H., Bscheider, M., Groß, O., Finger, K., Roth, S., Rebsamen, M., Hannesschläger, N., Schlee, M., Rothenfußer, S., Barchet, W., et al. (2009) · Nature Immunology · doi:10.1038/ni.1824 · Cited by 534
Uccellini, M. B., Broughton, C., Mackay, F., Akira, S., Marshak‐Rothstein, A., & Rifkin, I. R. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031942 · Cited by 528
Sequential Activation of Signaling Pathways during Innate Immune Responses in Drosophila
Boutros, M., Agaisse, H., & Perrimon, N. (2002) · Developmental Cell · doi:10.1016/s1534-5807(02)00325-8 · Cited by 533
Toll-like receptor 9 controls anti-DNA autoantibody production in murine lupus
Christensen, S. R., Kashgarian, M. J., Alexopoulou, L., Flavell, R. A., Akira, S., & Shlomchik, M. J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050338 · Cited by 521
Vollmer, J., Tluk, S., Schmitz, C., Hamm, S., Jurk, M., Forsbach, A., Akira, S., Kelly, K. M., Reeves, W. H., Bauer, S., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20051696 · Cited by 515
Goffic, R. L., Balloy, V., Lagranderie, M., Alexopoulou, L., Escriou, N., Flavell, R. A., Chignard, M., & Si‐Tahar, M. (2006) · PLoS Pathogens · doi:10.1371/journal.ppat.0020053 · Cited by 531
Thess, A., Grund, S., Mui, B. L., Hope, M. J., Baumhof, P., Fotin-Mleczek, M., & Schlake, T. (2015) · Molecular Therapy · doi:10.1038/mt.2015.103 · Cited by 513
NF-κB Family of Transcription Factors: Central Regulators of Innate and Adaptive Immune Functions
Caamaño, J., & Hunter, C. A. (2002) · Clinical Microbiology Reviews · doi:10.1128/cmr.15.3.414-429.2002 · Cited by 513
Innate immune mechanisms of mRNA vaccines
Verbeke, R., Hogan, M. J., Loré, K., & Pardi, N. (2022) · Immunity · doi:10.1016/j.immuni.2022.10.014 · Cited by 535
Hemagglutinin Protein of Wild-Type Measles Virus Activates Toll-Like Receptor 2 Signaling
Bieback, K., Lien, E., Klagge, I. M., Avota, E., Schneider‐Schaulies, J., Duprex, W. P., Wagner, H., Kirschning, C. J., ter Meulen, V., & Schneider‐Schaulies, S. (2002) · Journal of Virology · doi:10.1128/jvi.76.17.8729-8736.2002 · Cited by 516
Steinhagen, F., Kinjo, T., Bode, C., & Klinman, D. M. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.08.002 · Cited by 516
Essential role of IPS-1 in innate immune responses against RNA viruses
Kumar, H., Kawai, T., Kato, H., Sato, S., Takahashi, K., Coban, C., Yamamoto, M., Uematsu, S., Ishii, K. J., Takeuchi, O., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060792 · Cited by 503
Regulation of Toll/IL-1-receptor-mediated gene expression by the inducible nuclear protein IκBζ
Yamamoto, M., Yamazaki, S., Uematsu, S., Sato, S., Hemmi, H., Hoshino, K., Kaisho, T., Kuwata, H., Takeuchi, O., Takeshige, K., et al. (2004) · Nature · doi:10.1038/nature02738 · Cited by 498
Mechanisms of innate and adaptive immunity to the Pfizer-BioNTech BNT162b2 vaccine
Li, C., Lee, A., Grigoryan, L., Arunachalam, P. S., Scott, M. K. D., Trisal, M., Wimmers, F., Sanyal, M., Weidenbacher, P. A., Feng, Y., et al. (2022) · Nature Immunology · doi:10.1038/s41590-022-01163-9 · Cited by 505
Intratumoural administration and tumour tissue targeting of cancer immunotherapies
Melero, I., Álvarez, E. C., Álvarez, M., Champiat, S., & Marabelle, A. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-021-00507-y · Cited by 505
Beg, A. A. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02317-7 · Cited by 496
Toll-like receptors in health and disease in the brain: mechanisms and therapeutic potential
Hanke, M. L., & Kielian, T. (2011) · Clinical Science · doi:10.1042/cs20110164 · Cited by 498
Towards an immuno-precipitated neurodevelopmental animal model of schizophrenia
Meyer, U., Feldon, J., Schedlowski, M., & Yee, B. K. (2005) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2004.10.012 · Cited by 494
Toll-like receptors as adjuvant receptors
Kaisho, T., & Akira, S. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(01)00182-3 · Cited by 493
Castrillo, A., Joseph, S. B., Vaidya, S. A., Haberland, M. E., Fogelman, A. M., Cheng, G., & Tontonoz, P. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00384-8 · Cited by 498
Toll-like receptors 2 and 4 are up-regulated during intestinal inflammation
Hausmann, M., Kießling, S., Mestermann, S., Webb, G. R., Spöttl, T., Andus, T., Schölmerich, J., Herfarth, H. H., Ray, K., Falk, W., et al. (2002) · Gastroenterology · doi:10.1053/gast.2002.33662 · Cited by 488
Human Keratinocytes Express Functional Toll-Like Receptor 3, 4, 5, and 9
Lebre, M. C., van der Aar, A. M. G., van Baarsen, L. G. M., van Capel, T. M. M., Schuitemaker, J. H. N., Kapsenberg, M. L., & de Jong, E. C. (2006) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700530 · Cited by 517
Activation of Airway Epithelial Cells by Toll-Like Receptor Agonists
Sha, Q., Truong-Tran, A. Q., Plitt, J. R., Beck, L. A., & Schleimer, R. P. (2004) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2003-0388oc · Cited by 485
Groeger, S., & Meyle, J. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00208 · Cited by 473
Gasse, P., Mary, C., Guénon, I., Noulin, N., Charron, S., Schnyder‐Candrian, S., Schnyder, B., Akira, S., Quesniaux, V. F. J., Lagente, V., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32285 · Cited by 503
TLR3 Can Directly Trigger Apoptosis in Human Cancer Cells
Salaun, B., Coste, I., Rissoan, M., Lebecque, S., & Renno, T. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.8.4894 · Cited by 494
Nonself RNA-Sensing Mechanism of RIG-I Helicase and Activation of Antiviral Immune Responses
Takahasi, K., Yoneyama, M., Nishihori, T., Hirai, R., Kumeta, H., Narita, R., Gale, M., Inagaki, F., & Fujita, T. (2008) · Molecular Cell · doi:10.1016/j.molcel.2007.11.028 · Cited by 474
Modulation of the Immune Response to Respiratory Viruses by Vitamin D
Greiller, C. L., & Martineau, A. R. (2015) · Nutrients · doi:10.3390/nu7064240 · Cited by 478
Classification of current anticancer immunotherapies
Galluzzi, L., Vacchelli, E., Pedro, J. M. B., Buqué, A., Senovilla, L., Baracco, E. E., Bloy, N., Castoldi, F., Abastado, J., Agostinis, P., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2998 · Cited by 481
The Yin and Yang of type I interferon activity in bacterial infection
Decker, T., Müller, M. M., & Stockinger, S. (2005) · Nature reviews. Immunology · doi:10.1038/nri1684 · Cited by 486
Modern Subunit Vaccines: Development, Components, and Research Opportunities
Moyle, P. M., & Tóth, I. (2013) · ChemMedChem · doi:10.1002/cmdc.201200487 · Cited by 479
Ligand-induced conformational changes allosterically activate Toll-like receptor 9
Latz, E., Verma, A., Visintin, A., Gong, M., Sirois, C. M., Klein, D. C. G., Monks, B. G., McKnight, C. J., Lamphier, M. S., Duprex, W. P., et al. (2007) · Nature Immunology · doi:10.1038/ni1479 · Cited by 462
Zhang, Z., Ohto, U., Shibata, T., Krayukhina, E., Taoka, M., Yamauchi, Y., Tanji, H., Isobe, T., Uchiyama, S., Miyake, K., et al. (2016) · Immunity · doi:10.1016/j.immuni.2016.09.011 · Cited by 461
Triantafilou, M., Gamper, F. G. J., Haston, R. M., Mouratis, M. A., Morath, S., Härtung, T., & Triantafilou, K. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602794200 · Cited by 471
Innate Immunity in the Respiratory Epithelium
Parker, D., & Prince, A. S. (2011) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2011-0011rt · Cited by 474
The microglial "activation" continuum: from innate to adaptive responses
Town, T., Nikolic, V., & Tan, J. (2005) · Journal of Neuroinflammation · doi:10.1186/1742-2094-2-24 · Cited by 466
Oppenheim, D. E., Roberts, S. J., Clarke, S. L., Filler, R. B., Lewis, J., Tigelaar, R. E., Girardi, M., & Hayday, A. (2005) · Nature Immunology · doi:10.1038/ni1239 · Cited by 472
Totura, A. L., Whitmore, A. C., Agnihothram, S., Schäfer, A., Katze, M. G., Heise, M. T., & Baric, R. S. (2015) · mBio · doi:10.1128/mbio.00638-15 · Cited by 487
Induction and Regulation of IFNs During Viral Infections
Malmgaard, L. (2004) · Journal of Interferon & Cytokine Research · doi:10.1089/1079990041689665 · Cited by 456
Chemical Modification of siRNAs for In Vivo Use
Behlke, M. A. (2008) · Oligonucleotides · doi:10.1089/oli.2008.0164 · Cited by 464
Yoshitomi, H., Sakaguchi, N., Kobayashi, K., Brown, G. D., Tagami, T., Sakihama, T., Hirota, K., Tanaka, S., Nomura, T., Miki, I., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041758 · Cited by 452
Toll-like receptors: linking innate and adaptive immunity
Pasare, C., & Medzhitov, R. M. (2004) · Microbes and Infection · doi:10.1016/j.micinf.2004.08.018 · Cited by 461
Matsumoto, M., Kikkawa, S., Kohase, M., Miyake, K., & Seya, T. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00380-7 · Cited by 459
Sivori, S., Falco, M., Chiesa, M. D., Carlomagno, S., Vitale, M., Moretta, L., & Moretta, A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403744101 · Cited by 468
Antiviral Signaling Through Pattern Recognition Receptors
Kawai, T., & Akira, S. (2006) · The Journal of Biochemistry · doi:10.1093/jb/mvm032 · Cited by 452
Negishi, H., Taniguchi, T., & Yanai, H. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a028423 · Cited by 467
Heikenwalder, M., Polymenidou, M., Junt, T., Sigurdson, C., Wagner, H., Akira, S., Zinkernagel, R., & Aguzzi, A. (2004) · Nature Medicine · doi:10.1038/nm987 · Cited by 449
Karikó, K., Bhuyan, P. K., Capodici, J., & Weissman, D. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.11.6545 · Cited by 446
Robbins, M., Judge, A. D., & MacLachlan, I. (2009) · Oligonucleotides · doi:10.1089/oli.2009.0180 · Cited by 463
TLR3 is an endogenous sensor of tissue necrosis during acute inflammatory events
Cavassani, K. A., Ishii, M., Wen, H., Schaller, M. A., Lincoln, P., Lukacs, N. W., Hogaboam, C. M., & Kunkel, S. L. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20081370 · Cited by 447
Hoebe, K. H. N., Janssen, E. M., Kim, S. O., Alexopoulou, L., Flavell, R. A., Han, J., & Beutler, B. (2003) · Nature Immunology · doi:10.1038/ni1010 · Cited by 444
Detection of Microbial Infections Through Innate Immune Sensing of Nucleic Acids
Tan, J. X., Sun, L., Chen, J., & Chen, Z. J. (2018) · Annual Review of Microbiology · doi:10.1146/annurev-micro-102215-095605 · Cited by 449
Use of defined TLR ligands as adjuvants within human vaccines
Duthie, M. S., Windish, H. P., Fox, C. B., & Reed, S. G. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2010.00978.x · Cited by 437
Brinkmann, M. M., Spooner, E., Hoebe, K., Beutler, B., Ploegh, H. L., & Kim, Y.-M. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200612056 · Cited by 411
Toll-like receptors induce a phagocytic gene program through p38
Doyle, S. E., O'Connell, R. M., Miranda, G. A., Vaidya, S. A., Chow, E. K., Liu, P. T., Suzuki, S., Suzuki, N., Modlin, R. L., Yeh, W.-C., et al. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031237 · Cited by 433
Toll-like receptors and innate immunity
Uematsu, S., & Akira, S. (2006) · Journal of Molecular Medicine · doi:10.1007/s00109-006-0084-y · Cited by 445
Tissue-Specific mRNA Expression Profiles of Human Toll-Like Receptors and Related Genes
Nishimura, M., & Naito, S. (2005) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.28.886 · Cited by 443
Toll-Like Receptor Signaling Inhibits Hepatitis B Virus Replication In Vivo
Isogawa, M., Robek, M. D., Furuichi, Y., & Chisari, F. V. (2005) · Journal of Virology · doi:10.1128/jvi.79.11.7269-7272.2005 · Cited by 443
Toll-like receptor gene family and TIR-domain adapters in Danio rerio
Jault, C., Pichon, L., & Chluba, J. (2003) · Molecular Immunology · doi:10.1016/j.molimm.2003.10.001 · Cited by 440
Hochrein, H., Schlatter, B., O’Keeffe, M. A., Wagner, C., Schmitz, F., Schiemann, M., Bauer, S., Suter, M., & Wagner, H. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403555101 · Cited by 439
ADAR1 restricts ZBP1-mediated immune response and PANoptosis to promote tumorigenesis
Karki, R., Sundaram, B., Sharma, B. R., Lee, S., Malireddi, R. K. S., Nguyen, L. N., Christgen, S. L., Zheng, M., Wang, Y., Samir, P., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109858 · Cited by 444
Dalod, M., Chelbi, R., MALISSEN, B., & Lawrence, T. (2014) · The EMBO Journal · doi:10.1002/embj.201488027 · Cited by 468
Wolfram, J., & Mauro Ferrari, B. (2019) · Nano Today · doi:10.1016/j.nantod.2019.02.005 · Cited by 447
Goffic, R. L., Pothlichet, J., Vitour, D., Fujita, T., MEURS, E. F., Chignard, M., & Si‐Tahar, M. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.6.3368 · Cited by 448
Stills, H. F. (2005) · ILAR Journal · doi:10.1093/ilar.46.3.280 · Cited by 436
Alexopoulou, L., Thomas, V., Schnare, M., Lobet, Y., Anguíta, J., Schoen, R. T., Medzhitov, R. M., Fikrig, E., & Flavell, R. A. (2002) · Nature Medicine · doi:10.1038/nm732 · Cited by 445
Besch, R., Poeck, H., Hohenauer, T., Senft, D., Häcker, G. A., Berking, C., Hornung, V., Endres, S., Ruzicka, T., Rothenfußer, S., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37155 · Cited by 434
Toll-like receptors in neurodegeneration
Okun, E., Griffioen, K. J. S., Lathia, J. D., Tang, S., Mattson, M. P., & Arumugam, T. V. (2008) · Brain Research Reviews · doi:10.1016/j.brainresrev.2008.09.001 · Cited by 444
Toll-like receptor signaling in bony fish
Rebl, A., Goldammer, T., & Seyfert, H. (2009) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2009.09.021 · Cited by 438
Summary and comparison of the signaling mechanisms of the Toll/interleukin-1 receptor family
Martin, M. U., & Wesche, H. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(02)00320-8 · Cited by 439
Therapeutic Targeting of Toll-Like Receptors for Infectious and Inflammatory Diseases and Cancer
O'Neill, L. A. J., Bryant, C. E., & Doyle, S. (2009) · Pharmacological Reviews · doi:10.1124/pr.109.001073 · Cited by 429
Yang, Y., Huang, C.-T., Huang, X., & Pardoll, D. M. (2004) · Nature Immunology · doi:10.1038/ni1059 · Cited by 425
Schiavoni, G., Mattei, F., Sestili, P., Borghi, P., Venditti, M., Morse, H. C., Belardelli, F., & Gabriele, L. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20021263 · Cited by 423
Yadav, M., & Schorey, J. S. (2006) · Blood · doi:10.1182/blood-2006-05-024406 · Cited by 422
The adaptor protein CARD9 is required for innate immune responses to intracellular pathogens
Hsu, Y.-M. S., Zhang, Y., You, Y., Wang, D., Li, H., Duramad, O., Qin, F. X.-F., Dong, C., & Lin, X. (2006) · Nature Immunology · doi:10.1038/ni1426 · Cited by 420
Takeda, K., & Akira, S. (2015) · Current Protocols in Immunology · doi:10.1002/0471142735.im1412s109 · Cited by 422
Sioud, M. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.03.013 · Cited by 422
Wicherska‐Pawłowska, K., Wróbel, T., & Rybka, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413397 · Cited by 451
Devaraj, S. G., Wang, N., Chen, Z., Chen, Z., Tseng, M., Barretto, N., Lin, R., Peters, C. J., Tseng, C.-T. K., Baker, S. C., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704870200 · Cited by 411
Means, T. K., Hayashi, F., Smith, K. D., Aderem, A. A., & Luster, A. D. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.10.5165 · Cited by 416
Oshiumi, H., Sasai, M., Shida, K., Fujita, T., Matsumoto, M., & Seya, T. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305820200 · Cited by 413
Caron, G., Duluc, D., Frémaux, I., Jeannin, P., David, C., Gascan, H., & Delneste, Y. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.3.1551 · Cited by 417
A universal role for MyD88 in TLR/IL-1R-mediated signaling
Janssens, S., & Beyaert, R. (2002) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(02)02145-x · Cited by 417
Systemic immune challenges trigger and drive Alzheimer-like neuropathology in mice
Krstic, D., Madhusudan, A., Doehner, J., Vogel, P., Notter, T., Imhof, C., Manalastas, A., Hilfiker, M., Pfister, S., Schwerdel, C., et al. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-151 · Cited by 400
Ultraviolet radiation damages self noncoding RNA and is detected by TLR3
Bernard, J. J., Cowing-Zitron, C., Nakatsuji, T., Muehleisen, B., Muto, J., Borkowski, A. W., Martinez, L., Greidinger, E. L., Yu, B., & Gallo, R. L. (2012) · Nature Medicine · doi:10.1038/nm.2861 · Cited by 408
Toll-like receptor 8 senses degradation products of single-stranded RNA
Tanji, H., Ohto, U., Shibata, T., Taoka, M., Yamauchi, Y., Isobe, T., Miyake, K., & Shimizu, T. (2015) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2943 · Cited by 404
TOLL-like receptors linking innate and adaptive immune response
Werling, D., & Jungi, T. W. (2002) · Veterinary Immunology and Immunopathology · doi:10.1016/s0165-2427(02)00228-3 · Cited by 408
RNA Drugs and RNA Targets for Small Molecules: Principles, Progress, and Challenges
Yu, A., Choi, Y. H., & Tu, M. (2020) · Pharmacological Reviews · doi:10.1124/pr.120.019554 · Cited by 421
Perry, A. K., Chow, E. K., Goodnough, J. B., Yeh, W., & Cheng, G. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040528 · Cited by 396
Interferons and viral infections
Fensterl, V., & Sen, G. C. (2009) · BioFactors · doi:10.1002/biof.6 · Cited by 406
Gandhi, N. S., Tekade, R. K., & Chougule, M. B. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.09.001 · Cited by 402
Yang, P., An, H., Liu, X., Wen, M., Zheng, Y., Rui, Y., & Cao, X. (2010) · Nature Immunology · doi:10.1038/ni.1876 · Cited by 409
Acute exacerbations of asthma: epidemiology, biology and the exacerbation‐prone phenotype
Dougherty, R. H., & Fahy, J. V. (2009) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2008.03157.x · Cited by 400
TLR9 as a key receptor for the recognition of DNA☆
Kumagai, Y., Takeuchi, O., & Akira, S. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.12.004 · Cited by 404
Toll‐like receptors, endogenous ligands, and systemic autoimmune disease
Rifkin, I. R., Leadbetter, E. A., Busconi, L., Viglianti, G. A., & Marshak‐Rothstein, A. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00239.x · Cited by 384
Jiang, Z., Mak, T. W., Sen, G. C., & Li, X. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308496101 · Cited by 388
Metadata
- Authors
- Alexopoulou, L., Holt, A. C., Medzhitov, R., & Flavell, R. A.
- Affiliations
- Yale University (US)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Medzhitov, Ruslan
- Flavell, Richard A.
- Venue
- Nature
- Published
- 2001-10
- Volume
- 413
- Issue
- 6857
- Pages
- 732-738
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2076361525
- Cited by
- 6,129
- References
- 30
- Citations by year
- 2026: 134 · 2025: 156 · 2024: 161 · 2023: 174 · 2022: 203 · 2021: 270 · 2020: 216 · 2019: 203 · 2018: 209 · 2017: 209 · 2016: 219 · 2015: 237 · 2014: 258 · 2013: 279 · 2012: 303
- FWCI
- 66.43
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Keywords
- TLR3, double-stranded RNA, NF-κB activation, type I interferon, MyD88, poly(I:C), innate immunity, viral infection, MAPK signaling, dendritic cell maturation, inflammatory cytokines
- MeSH terms
- Amino Acid Sequence, Animals, Antigens, Differentiation, B-Lymphocytes, Cell Line, Cells, Cultured, Galactosamine, Humans, Interferon Type I, Lymphocyte Activation, Macrophages, Membrane Glycoproteins, Molecular Sequence Data, Poly I-C, Receptors, Cell Surface, Receptors, Immunologic, RNA, Double-Stranded, Virus Diseases, Signal Transduction, Cytokines, NF-kappa B, Sequence Homology, Amino Acid, Mitogen-Activated Protein Kinases, Drosophila Proteins, Adaptor Proteins, Signal Transducing, Toll-Like Receptors, Toll-Like Receptor 3, Mice, Myeloid Differentiation Factor 88
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review